|
FER expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.095770E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.102480E-02 |
| Normal-vs-Stage2 |
1.933770E-02 |
| Normal-vs-Stage3 |
3.812400E-01 |
| Normal-vs-Stage4 |
1.427950E-02 |
| Stage1-vs-Stage2 |
6.336200E-01 |
| Stage1-vs-Stage3 |
3.919800E-01 |
| Stage1-vs-Stage4 |
3.561800E-01 |
| Stage2-vs-Stage3 |
3.342000E-01 |
| Stage2-vs-Stage4 |
5.711400E-01 |
| Stage3-vs-Stage4 |
2.415600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.003950E-02 |
| Normal-vs-AfricanAmerican |
3.328100E-02 |
| Normal-vs-Asian |
6.832800E-01 |
| Caucasian-vs-AfricanAmerican |
9.106600E-01 |
| Caucasian-vs-Asian |
7.421400E-01 |
| AfricanAmerican-vs-Asian |
6.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.478620E-03 |
| Normal-vs-Female |
8.489200E-01 |
| Male-vs-Female |
1.123850E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.138200E-03 |
| Normal-vs-Extreme_Weight |
3.457000E-03 |
| Normal-vs-Obese |
3.916800E-01 |
| Normal-vs-Extreme_Obese |
1.317700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.094800E-01 |
| Normal_Weight-vs-Obese |
8.336300E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.705400E-01 |
| Extreme_Weight-vs-Obese |
3.234200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.096000E-01 |
| Obese-vs-Extreme_Obese |
1.830780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.728800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.057000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.438400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.55769999998778E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.631550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.866000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.237570E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.21459999999652E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.372320E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.557800E-03 |
| Normal-VS-Type2 PRCC |
1.185770E-02 |
| Normal-VS-KIRP CIMP |
7.770000E-01 |
| Normal-VS-Unclassified PRCC |
9.586600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.387800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.157800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.758000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.255000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.417600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.215800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.216200E-04 |
| Normal-vs-N1 |
7.592600E-01 |
| Normal-vs-N2 |
4.167000E-01 |
| N0-vs-N1 |
5.520500E-02 |
| N0-vs-N2 |
4.659200E-01 |
| N1-vs-N2 |
7.198400E-01 |
|
|
